156 results
Page 4 of 8
424B5
zeqb 5kzf
13 Oct 20
Prospectus supplement for primary offering
5:24pm
8-K
33r5n3 f1g
13 Oct 20
Other Events
5:04pm
8-K
EX-99.1
o04uukbiq t6wv9vv5b
7 Oct 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
fd203r fbj
7 Aug 20
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
7:23am
8-K
EX-99.1
cygh9vrygu ruakbp
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
EX-99.1
x1wog4o
16 Jul 20
Results of Operations and Financial Condition
9:17am
8-K
qitqw
6 Jul 20
Other Events
8:15am
8-K
EX-99.1
m7rv8d8adj6afuy2ui7w
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-1.1
1tmjji kx
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-99.2
tqh 8kf61l3zo
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
424B5
0vlxuz
20 May 20
Prospectus supplement for primary offering
4:27pm
424B5
lvgclf8uwl16ap7gqwp
19 May 20
Prospectus supplement for primary offering
4:54pm
8-K
eln 4hpov93e8
14 May 20
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-99.1
c3s1g8r 4p9z6p6nm
8 May 20
Ocular Therapeutix™ Reports First Quarter 2020 Financial Results and Business Update
7:05am
8-K
EX-99.1
i1tu7
13 Apr 20
Ocular Therapeutix™ Provides Business Update and Response to COVID-19 Global Pandemic
8:05am